Expression Profiling
Quantification of genes and transcripts across samples, groups, conditions, and experimental models.
B&B Bio Next Generation Sequencing
RNA sequencing provides a detailed view of gene activity by quantifying RNA abundance and characterizing transcript structure across research samples.
B&B Bio helps researchers, laboratories, and biotechnology companies maintain high standards of quality and reproducibility through reliable authentication workflows.
Projects are reviewed for sample type, RNA quality, library strategy, sequencing depth, comparison groups, bioinformatics scope, and required deliverables before work begins.
Service Overview
Transcriptome sequencing quantifies RNA abundance to determine relative gene expression in tumor and other research samples. It can identify gene-expression profiles, gene fusions, alternative splicing, and allele-specific expression.
RNA sequencing can also characterize immune-marker expression and support research into cellular pathways, tumor subtype classification, proliferation, immune activity, and hypotheses related to treatment response. Findings are intended for research interpretation and not for clinical decision-making unless separately validated and authorized.
Quantification of genes and transcripts across samples, groups, conditions, and experimental models.
Project-specific options for fusion detection, splice-junction analysis, isoforms, and allele-specific expression.
Support for tumor biology, subtype research, proliferation signatures, pathway activity, and tumor-microenvironment studies.
Raw data, processed files, expression matrices, quality summaries, and selected reports are agreed before initiation.
RNA-Seq Capabilities
Quantify RNA abundance and compare expression patterns across samples, biological groups, or experimental conditions.
Investigate known and candidate expressed fusion transcripts using project-specific analysis methods.
Assess exon usage, splice junctions, and other transcript-structure features when included in the project plan.
Explore allele-specific expression and imprinting-related patterns in suitable research designs.
Characterize immune-marker expression and transcriptional activity in tumors and research models.
Support pathway research, tumor-subtype classification, proliferation studies, and functional interpretation.
Study groups, biological question, sample source, RNA type, quality, quantity, and required outputs are reviewed.
RNA quality is assessed and an appropriate library strategy is selected, such as poly(A) enrichment or ribosomal RNA depletion.
Libraries are sequenced using the agreed configuration, followed by demultiplexing, read-level QC, and alignment or transcript quantification.
Expression data, selected transcript analyses, quality summaries, files, and reports are delivered according to the project plan.
Study Design
Transcriptome profiling of tissues, tumors, cell populations, and experimental models.
RNA profiling of tumor and matched research materials to investigate expressed molecular features.
Expression profiling of human cell lines, engineered models, clones, and treatment-response experiments.
Sample Planning
RNA with documented concentration, volume, purity, integrity, extraction method, and storage conditions.
Source tissue or extracted RNA may be accepted after technical review and confirmation of preservation and quality requirements.
FFPE-derived RNA may require specialized library preparation and project-specific quality thresholds because of RNA fragmentation.
Cultured cells, cell pellets, and other research materials may be suitable depending on extraction, yield, integrity, and study design.
Measure thousands of expressed genes and transcripts within a single sequencing workflow.
RNA, library, sequencing, and analysis quality are reviewed at defined stages.
Analysis can be tailored to expression, fusion, splicing, immune, pathway, or model-system objectives.
Research materials, project information, and data are handled according to agreed requirements.
Demultiplexed FASTQ files and run-level quality information, as specified in the project plan.
BAM or CRAM files, transcript-abundance files, or gene-level count matrices aligned or quantified against the agreed reference.
Normalized expression matrices, differential-expression outputs, sample relationships, and selected visualizations when included.
Project-specific outputs may include gene-fusion candidates, splice-junction results, isoform analysis, or allele-specific expression.
Quality summaries, pathway or enrichment results, immune-marker summaries, and other research-focused reports may be provided by agreement.
Contact B&B Bio to define sample requirements, RNA quality criteria, library strategy, sequencing depth, comparison groups, analysis scope, and deliverables.
B&B Bio Transcriptome Sequencing services are intended for research use only and are not intended for diagnostic procedures or treatment selection unless separately validated and authorized under applicable regulations. Expression signatures, immune-marker findings, pathway analyses, fusion candidates, and other outputs require appropriate research interpretation and independent confirmation where applicable. Final sample acceptance criteria, library method, sequencing configuration, analytical methods, timeline, and deliverables are established in the approved project plan.